Advanced search×

ER regulates an evolutionarily conserved apoptosis pathway

Biochem Biophys Res Commun 400(1):5 (2010) PMID 20691160

Estrogen receptor (ER) is regarded as a major causal factor in breast cancer and FoxA1, a winged-helix transcription factor belonging to the forkhead family, has been found to function as a pioneer factor in the recruitment of ER to several cis-regulatory elements in the genome. High throughput chromatin immunoprecipitation analyzed by hybridization to microarrays (ChIP-chip) can reveal ER and FoxA1 binding sites occupied by transcription factors. However, these results are blind to lineage-specific cis-regulatory elements. In this study, we identified ER and FoxA1 binding sites conserved in evolution by using Detection of LinEage-Specific Selection (DLESS) method. We also analyzed target genes close to conserved cis-regulatory elements by combining gene-expression data. A total of 7877 ER binding sites and 18,135 FoxA1 binding sites were identified in MCF-7 cells by performing an unbiased genome-wide ChIP-chip with False Discovery Rate (FDR) of 5%. Using DLESS method, we found target candidate genes closest to fully conserved cis-regulatory elements related to apoptosis according to gene ontology analysis. Furthermore, network analysis of apoptosis-related genes within 10kb of fully conserved cis-regulatory elements was constructed using Ingenuity Pathway Analysis (IPA). Apoptosis genes in the network showed over- and under-expression in MCF-7 cell-line. And these apoptosis-related genes closest to fully conserved cis-regulatory elements in network showed strong correlation with ER in MCF-7 cells. These results elucidate that ER regulates an evolutionarily conserved apoptosis pathway. This opens up new perspectives in the apoptosis of human breast cancer from the evolution of cis-regulatory elements.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.bbrc.2010.07.132
Version: za2963e q8za3 q8zb1 q8zc0 q8zdc q8ze1 q8zfb q8zg9

Similar articles you may find interesting…

  1. Trends in the medical management of patients with heart failure.

    J Clin Med Res 5(3):194-204 (2013) PMID 23671545

    We reviewed the medical records of 9,748 residents of the Worcester, MA, metropolitan area who were hospitalized with ADHF at all 11 central Massachusetts medical centers in 1995, 2000, 2002, and 2004. Between 1995 and 2004, respectively, the prescription upon hospital discharge of b...
  2. Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study.

    Curr Diab Rep (2013) PMID 23649945

    Diabetic kidney disease causes significant morbidity and mortality among people with type 1 diabetes (T1D). Intensive glucose and blood pressure control have thus far failed to adequately curb this problem and therefore a major need for novel treatment approaches exists. Multiple obs...
  3. Mechanism of endogenous regulation of the type I interferon response by Suppressor of IKK{epsilon} (SIKE), a novel substrate of TANK binding...

    J Biol Chem (2013) PMID 23649622

    We describe the mechanism by which Suppressor of IKKε (SIKE) inhibits TBK1-mediated phosphorylation of interferon regulatory factor 3 (IRF3), essential to type I interferon production. Kinetic analyses showed that SIKE not only inhibits IRF3 phosphorylation, but is also a high-affinity, TBK1 substr...